S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q4 2022

BVF Partners

Period: Q4 2022 Β· Filed: 2023-02-14
View on SEC EDGAR β†—
AUM
$2.37B
Total portfolio value
Positions
78
Reported securities
Top Holding
MLTX
9.6% $228.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$228.4M9.64%$11.02$18.95+72.0%
9.6%
AXSMAXSOME THERAPEUTICS INC$135.4M5.71%$73.32$244.31+233.2%
5.7%
RPTXREPARE THERAPEUTICS INC$122.0M5.15%β€”β€”
5.2%
KYMRKYMERA THERAPEUTICS INC$117.1M4.94%$24.84$113.51+357.0%
4.9%
GHRSGH RESEARCH PLC$89.7M3.79%$9.67$27.01+179.3%
3.8%
FDMT4D MOLECULAR THERAPEUTICS IN$89.0M3.76%$20.64$13.00-37.0%
3.8%
CGEMCULLINAN ONCOLOGY INC$79.2M3.34%$10.68$17.63+65.1%
3.3%
RVMDREVOLUTION MEDICINES INC$77.5M3.27%$22.95$189.24+724.6%
3.3%
PNTPOINT BIOPHARMA GLOBAL INC$66.9M2.82%β€”β€”
2.8%
XOMAXOMA CORP DEL$66.5M2.80%$18.66$43.00+130.4%
2.8%
RLAYRELAY THERAPEUTICS INC$57.9M2.44%$15.04$18.65+24.0%
2.4%
CTICCTI BIOPHARMA CORP$53.0M2.24%β€”β€”
2.2%
ACRSACLARIS THERAPEUTICS INC$51.6M2.18%$15.07$5.56-63.1%
2.2%
XENEXENON PHARMACEUTICALS INC$50.1M2.12%$37.26$60.96+63.6%
2.1%
CRNXCRINETICS PHARMACEUTICALS IN$50.1M2.11%$18.10$42.23+133.3%
2.1%
RCUSARCUS BIOSCIENCES INC$47.6M2.01%$20.20$30.33+50.1%
2.0%
KURAKURA ONCOLOGY INC$47.2M1.99%$12.05$11.10-7.9%
2.0%
ZYMEZYMEWORKS DEL INC$46.1M1.95%$7.54$26.31+248.9%
1.9%
MRUSMERUS N V$46.1M1.94%β€”β€”
1.9%
IMVTIMMUNOVANT INC$45.5M1.92%$18.75$38.79+106.9%
1.9%
IONSIONIS PHARMACEUTICALS INC$42.4M1.79%$37.58$81.80+117.7%
1.8%
ALLKALLAKOS INC$42.2M1.78%β€”β€”
1.8%
REPLREPLIMUNE GROUP INC$41.4M1.75%$26.35$11.58-56.0%
1.8%
IDYAIDEAYA BIOSCIENCES INC$40.1M1.69%$17.38$37.65+116.6%
1.7%
SNDXSYNDAX PHARMACEUTICALS INC$36.9M1.56%$25.60$21.82-14.8%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$36.2M1.53%$28.50$19.40-31.9%
1.5%
ITOSITEOS THERAPEUTICS INC$35.4M1.49%β€”β€”
1.5%
LXRXLEXICON PHARMACEUTICALS INC$30.8M1.30%$1.99$2.32+16.6%
1.3%
GLYCGLYCOMIMETICS INC$28.9M1.22%β€”β€”
1.2%
RAINRAIN ONCOLOGY INC$28.2M1.19%β€”$1.97
1.2%

Quarter-on-Quarter Activity

Q4 2022 vs. Q3 2022

New Positions (8)

TickerIssuerNotionalSince Filing
AXSMAXSOME THERAPEUTICS INC$135.4M+233.2%
ZYMEZYMEWORKS DEL INC$46.1M+248.9%
IMVTIMMUNOVANT INC$45.5M+106.9%
NAMSNEWAMSTERDAM PHARMA COMPANY$16.0M
NLSPNLS PHARMACEUTICS LTD$7.4M
ARAVARAVIVE INC$6.3M
LKFTGALAPAGOS NV$4.4M
IMUXIMMUNIC INC$1.6M

Exited Positions (8)

TickerIssuerNotional
RLMDRELMADA THERAPEUTICS INC$76.9M
CINCCINCOR PHARMA INC$43.1M
NUVLNUVALENT INC$32.4M
EQRXEQRX INC$29.7M
ETNB89BIO INC$18.2M
SPROSPERO THERAPEUTICS INC$3.9M
FWPAYFORWARD PHARMA A/S$1.5M
MEIPXXXXMEI PHARMA INC$1.4M

Increased (6)

TickerIssuerNotionalShares Ξ”Since Filing
REPLREPLIMUNE GROUP INC$25.4M+64.3%-56.0%
PNTPOINT BIOPHARMA GLOBAL INC$23.7M+64.2%
XFORXXXXX4 PHARMACEUTICALS INC$-0.1M+58.9%
XENEXENON PHARMACEUTICALS INC$17.6M+41.1%+63.6%
THRDTHIRD HARMONIC BIO INC$-47.7M+24.7%
KURAKURA ONCOLOGY INC$3.4M+18.6%-7.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
GBIOGENERATION BIO CO$-1.5M-71.6%
IONSIONIS PHARMACEUTICALS INC$-84.7M-61.0%+117.7%
COGTCOGENT BIOSCIENCES INC$-19.7M-52.8%
WHWKAADI BIOSCIENCE INC$-5.2M-36.0%
HLVXHILLEVAX INC$-2.4M-35.0%
IDYAIDEAYA BIOSCIENCES INC$-9.1M-33.1%+116.6%
VRDNVIRIDIAN THERAPEUTICS INC$0.5M-28.9%-31.9%
CRNXCRINETICS PHARMACEUTICALS IN$-22.2M-25.6%+133.3%
← Back to Hedge Funds